Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:moxifloxacin
|
| gptkbp:activities |
forms a protective barrier on the ulcer
|
| gptkbp:appointed_by |
oral tablet
|
| gptkbp:approves |
gptkb:1984
gptkb:FDA |
| gptkbp:brand |
Carafate
|
| gptkbp:category |
B
|
| gptkbp:class |
gastrointestinal agent
|
| gptkbp:clinical_trial |
Phase IV
|
| gptkbp:contraindication |
hypersensitivity to sucralfate
|
| gptkbp:counseling_services |
take on an empty stomach
report any allergic reactions do not take with antacids may cause stool discoloration |
| gptkbp:current_use |
peptic ulcer disease
gastroesophageal reflux disease stress ulcers |
| gptkbp:dosage_form |
gptkb:tablet
suspension 1 gram four times daily |
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
sucralfate
|
| gptkbp:ingredients |
C12 H54 Al16 O75 S6
|
| gptkbp:interacts_with |
gptkb:phenytoin
gptkb:digoxin gptkb:warfarin antacids |
| gptkbp:is_atype_of |
A02 B X01
|
| gptkbp:is_available_on |
generic medication
|
| gptkbp:is_used_for |
treatment of ulcers
|
| gptkbp:lifespan |
approximately 6 hours
|
| gptkbp:manager |
oral
|
| gptkbp:metabolism |
minimal
|
| gptkbp:research_focus |
combination therapy
drug interactions pediatric use long-term use effects elderly use gastrointestinal safety mucosal protection ulcer healing |
| gptkbp:side_effect |
nausea
constipation dry mouth gastric discomfort |
| gptkbp:suitable_for |
chronic kidney disease
severe renal impairment aluminum toxicity |
| gptkbp:type_of |
77474-68-3
|